Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study.
Wagner MJ, Hennessy C, Beeghly A, French B, Shah DP, Croessmann S, Vilar-Compte D, Ruiz-Garcia E, Ingham M, Schwartz GK, Painter CA, Chugh R, Fecher L, Park C, Zamulko O, Trent JC, Subbiah V, Khaki AR, Tachiki L, Nakasone ES, Loggers ET, Labaki C, Saliby RM, McKay RR, Ajmera A, Griffiths EA, Puzanov I, Tap WD, Hwang C, Tejwani S, Jhawar SR, Hayes-Lattin B, Wulff-Burchfield E, Kasi A, Reuben DY, Nagaraj G, Joshi M, Polimera H, Kulkarni AA, Esfahani K, Kwon DH, Paoluzzi L, Bilen MA, Durbin EB, Grivas P, Warner JL, Davis EJ; COVID-19 and Cancer Consortium. Wagner MJ, et al. Among authors: ingham m. Cancers (Basel). 2022 Sep 5;14(17):4334. doi: 10.3390/cancers14174334. Cancers (Basel). 2022. PMID: 36077869 Free PMC article.
Cell-Cycle Therapeutics Come of Age.
Ingham M, Schwartz GK. Ingham M, et al. J Clin Oncol. 2017 Sep 1;35(25):2949-2959. doi: 10.1200/JCO.2016.69.0032. Epub 2017 Jun 3. J Clin Oncol. 2017. PMID: 28580868 Free PMC article. Review.
Emerging Targeted and Immune-Based Therapies in Sarcoma.
Pollack SM, Ingham M, Spraker MB, Schwartz GK. Pollack SM, et al. Among authors: ingham m. J Clin Oncol. 2018 Jan 10;36(2):125-135. doi: 10.1200/JCO.2017.75.1610. Epub 2017 Dec 8. J Clin Oncol. 2018. PMID: 29220291 Review.
Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN).
Kasper B, Achee A, Schuster K, Wilson R, van Oortmerssen G, Gladdy RA, Hemming ML, Huang P, Ingham M, Jones RL, Pollack SM, Reinke D, Sanfilippo R, Schuetze SM, Somaiah N, Van Tine BA, Wilky B, Okuno S, Trent J. Kasper B, et al. Among authors: ingham m. Cancers (Basel). 2021 Feb 20;13(4):886. doi: 10.3390/cancers13040886. Cancers (Basel). 2021. PMID: 33672607 Free PMC article. Review.
What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?
Kasper B, D'Ambrosio L, Davis EJ, Ingham M, Broto JM, Trent JC, van Houdt WJ, Van Tine BA. Kasper B, et al. Among authors: ingham m. Curr Treat Options Oncol. 2022 Mar;23(3):439-449. doi: 10.1007/s11864-021-00928-y. Epub 2022 Mar 11. Curr Treat Options Oncol. 2022. PMID: 35275323 Free PMC article. Review.
Novel Therapeutics in the Treatment of Uterine Sarcoma.
Bose S, Schwartz GK, Ingham M. Bose S, et al. Among authors: ingham m. Am Soc Clin Oncol Educ Book. 2022 Apr;42:900-909. doi: 10.1200/EDBK_350541. Am Soc Clin Oncol Educ Book. 2022. PMID: 35714303 Free article.
79 results